Correction to: Scientific Reports https://doi.org/10.1038/s41598-025-15156-9, published online 12 August 2025
The original version of this Article contained an error where an incorrect version of Fig. 3 was published. The original Fig. 3 and accompanying legend appear below.
Genomic landscape of cases from the OmniSeq HGSOC cohort. The histogram below shows the prevalence and type of alterations for the most commonly altered genes in the OmniSeq HGSOC cohort. Of note, 100% of the tumors harbored pathogenic alterations in TP53 (not shown).
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Strickland, K.C., Wallen, Z.D., Ko, H.C. et al. Correction: RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer. Sci Rep 15, 36994 (2025). https://doi.org/10.1038/s41598-025-23530-w
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-23530-w
